What are the recommended starting and maximum doses of hydralazine in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydralazine Dosing for Adults

For intravenous hydralazine in hypertensive emergencies, start with 10 mg via slow IV infusion (maximum initial dose 20 mg) and repeat every 4-6 hours as needed. 1, 2, 3, 2, 4, 1, 5, 2, 5

Intravenous Dosing (Hypertensive Emergencies)

Starting dose: 10 mg IV (slow infusion)

  • Maximum initial dose: 20 mg
  • Repeat dosing: Every 4-6 hours as needed
  • Onset: 10-30 minutes
  • Duration: 2-4 hours

Critical Caveats for IV Use

The 2017 ACC/AHA guidelines explicitly state that hydralazine is NOT a desirable first-line agent for acute hypertensive emergencies due to:

  • Unpredictability of blood pressure response
  • Prolonged duration of action (2-4 hours)
  • Slower onset compared to other agents 1, 2, 3, 2, 4, 1, 5, 2, 5

Preferred alternatives include nicardipine, clevidipine, or labetalol for most hypertensive emergencies, which offer more titratable and predictable responses.

Oral Dosing (Chronic Hypertension/Heart Failure)

Starting dose: 10 mg orally 2-4 times daily (or 25 mg twice daily)

  • Titration: Increase gradually over 2-4 weeks
  • Maximum dose: 300 mg/day (divided doses)
  • Typical maintenance: 50-100 mg twice daily

Oral Dosing Details from FDA Label

For adults with chronic conditions 6:

  • Initial: 10 mg four times daily for 2-4 days
  • Increase to 25 mg four times daily for remainder of first week
  • Further increase to 50 mg four times daily from second week onward
  • Maximum daily dose: 300 mg (some sources cite 200 mg as maximum recommended dose)

Special Consideration: Heart Failure with Reduced Ejection Fraction

For HFrEF, particularly in Black patients, hydralazine is used in combination with isosorbide dinitrate 7:

  • Fixed-dose combination starting dose: 20 mg isosorbide dinitrate + 37.5 mg hydralazine three times daily
  • Target dose: 40 mg isosorbide dinitrate + 75 mg hydralazine three times daily
  • Maximum: 120 mg isosorbide dinitrate + 300 mg hydralazine total daily (divided doses)

Pregnancy-Specific Dosing

For severe hypertension in pregnancy (preeclampsia/eclampsia) 8:

  • Initial: 5 mg IV or IM
  • Repeat: 5-10 mg every 20-40 minutes
  • Maximum cumulative dose: 20 mg
  • Alternative: Constant infusion 0.5-10 mg/hour
  • Onset: 10-20 minutes

Important: While hydralazine is used in pregnancy, it may cause more maternal hypotension, headaches, and abnormal fetal heart rate tracings compared to labetalol or nifedipine 8.

Pediatric Dosing

From FDA label 6:

  • Starting dose: 0.75 mg/kg/day divided into 4 doses
  • Maximum: 7.5 mg/kg/day or 200 mg/day (whichever is lower)
  • Increase gradually over 3-4 weeks

Key Clinical Pitfalls

  1. Acetylator status matters: Slow acetylators (NAT2 poor metabolizers) have higher plasma concentrations and increased risk of drug-induced lupus 9. Consider lower doses in this population.

  2. Reflex tachycardia: Hydralazine causes significant sympathetic activation. Often requires concurrent beta-blocker to prevent tachycardia and anginal symptoms 6.

  3. Drug-induced lupus: Risk increases with:

    • Doses >200 mg/day
    • Prolonged therapy (>6 months)
    • Slow acetylator phenotype
    • Monitor ANA titers periodically 6
  4. Food interaction: Administration with food increases plasma levels 6. Maintain consistent timing relative to meals.

  5. Dosing frequency: While 300 mg/day can be given twice daily with similar efficacy to four times daily dosing, most guidelines recommend divided doses 3-4 times daily for chronic use 10.

  6. Coronary artery disease: Use with extreme caution—can precipitate myocardial ischemia or infarction due to reflex tachycardia and increased myocardial oxygen demand 6.

References

Research

Duration of hydralazine action in hypertension.

Clinical pharmacology and therapeutics, 1975

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.